
Oxford BioMedica signals potential openness to PE bid despite rejecting EQT offers
Oxford BioMedica has indicated it could consider a private equity takeover under the right circumstances, even after rejecting multiple unsolicited approaches from Sweden’s EQT earlier this year, according to a report by the Financial Times citing comments from its chief executive.
